CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Daily consensus interferon versus peg-interferon alfa2b with weight based ribavirin in treatment-naive patients with chronic hepatitis C serotype-1
DOI 10.1055/s-2007-988513
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Schuchmann, H Löhr, R Link, P Buggisch, M Fuchs, S Kaiser, C Antoni, T Witthöft, J Schlaak, P Galle, W Böcher
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe09/2007
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Consensus interferon (CIFN) is a synthetic type 1 interferon with enhanced in vitro activity compared to conventional IFN-alfa (IFNa). In the prospective, randomized multicenter PegIntron-Against-Consensus-Trial (PACT), the efficacy and safety of daily CIFN-treatment and ribavirin is compared to PegInterferon (PegIFN) alfa2b plus ribavirin. At the meeting, we will present final results of all 291 patie…
Zitieren
Zitierempfehlung
M Schuchmann, H Löhr, R Link, P Buggisch, M Fuchs, S Kaiser, C Antoni, T Witthöft, J Schlaak, P Galle, W Böcher (2007) Daily consensus interferon versus peg-interferon alfa2b with weight based ribavirin in treatment-naive patients with chronic hepatitis C serotype-1. Zeitschrift für Gastroenterologie (09). https://doi.org/10.1055/s-2007-988513
Mit CareLit weiterarbeiten